Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin’s Lymphoma

Nov 5th, 2009
by admin.

FRAZER, Pa., Nov. 5 (HSMN NewsFeed) — Cephalon, Inc. (Nasdaq: CEPH ) today announced the journal Cancer has published a pivotal study demonstrating that TREANDA(R) (bendamustine HCl) for Injection induced durable responses in patients with indolent B-ce…
Biopharmaceuticals, Oncology
Cephalon, TREANDA, bendamustine, non-Hodgkin’s lymphoma

Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin’s Lymphoma

Posted in: Medical Sales Jobs.

← AtriCure Announces Tentative Settlement with the Department of Justice
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States →

0 Comments on “Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin’s Lymphoma”

Leave a Comment